Scion Pharmaceuticals, Inc.
News and overview for Scion Pharmaceuticals, Inc.
MGSCOMM Accelerates Growth Through Merger With NY-Based Reynardus & Moya [Press Release]
PRNewswire | 104 days 9 hours 2 minutes ago
...include: Southeast Toyota Distributors, Scion, Publix Super Markets, BB&T financial...president, CMO, ITT Educational Services, Inc. The merger announcement follows...goods, retail, healthcare, financial, pharmaceuticals, tourism and luxury products; and is...
1 Results
Sign up for ANA SmartBrief
Company Overview
| Company: | Scion Pharmaceuticals, Inc. |
|---|---|
| Industry: | Biopharmaceuticals & Biotherapeutics |
| Website: | http://www.scionpharma.com |
Scion Pharmaceuticals is doing a little channel surfing. The development-stage biotechnology firm focuses on ion channels and receptors in its quest to create new therapies for cardiovascular and central nervous system disorders, including chronic pain and atrial fibrillation (a common form of arrhythmia). The opening and closing of ion channels in the cell membrane that allow the exchange of molecules help set the beat in heart muscle cells and contribute to how the human mind operates and how humans behave. Scion Pharmaceuticals uses electrophysiology assays developed at Boston University in its research and development.
Key Numbers
| Sales in U.S. Dollars (mil.) | 3 (2005) |
|---|---|
| One-year % Growth in Sales | 0.0 (2005) |
| Net Income in U.S. Dollars (mil.) | 0 () |
| One-year % Growth in Net Income | 0.0 () |
| Number of Employees | 40 (2005) |
| One-year % Growth in Number of Employees | 0.0 (2005) |
| Fiscal Year-End | December |